Shionogi & Co., Ltd. (SGIOF)

Market Cap	18.68B +44.4%
Revenue (ttm)	2.97B +1.9%
Net Income	1.24B +15.5%
EPS	1.46 +15.7%
Shares Out	n/a
PE Ratio	15.04
Forward PE	n/a
Dividend	0.43 (2.14%)
Ex-Dividend Date	Mar 30, 2026

Volume	600
Average Volume	7,104
Open	20.02
Previous Close	21.45
Day's Range	20.02 - 20.02
52-Week Range	14.25 - 26.00
Beta	0.02
RSI	51.19
Earnings Date	May 8, 2026

About Shionogi &

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Osaka, Japan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1878
• Employees: 4,955
• Stock Exchange: OTCMKTS
• Ticker Symbol: SGIOF

Financial Performance

In fiscal year 2025, Shionogi &'s revenue was 438.27 billion, an increase of 0.73% compared to the previous year's 435.08 billion. Earnings were 170.44 billion, an increase of 5.19%.

Financial numbers in JPY